The cell and gene therapy revolution is global. With clinical trials being conducted in countries around the world and commercial therapies reaching new patient populations every year, the need for integrated, compliant, and scalable supply chain support has never been more urgent. Yet many life science companies are still navigating a disjointed landscape of regional supply chain providers, customs requirements, and inconsistent quality frameworks.

At Cryoport Systems, we believe that patient access is the next hurdle the industry will need to tackle. That’s why we’re building a global network designed not just to move materials, but to unify the advanced therapy supply chain. Through an expanding footprint of strategically located facilities, regulatory expertise and support, and integrated supply chain services, we are helping organizations bring breakthrough therapies to markets more efficiently and with reduced risk.

A Global Vision, now a Reality

Over the past several years, Cryoport Systems has made substantial investments to expand and integrate our worldwide capabilities. Our approach is grounded in the…